Novartis plans spinoff of Alcon, $5 billion share buy-back

Novartis plans spinoff of Alcon, $5 billion share buy-back Joerg Reinhardt said "The review concluded that a spinoff would be in the best interests of Novartis shareholders."

No comments:

Post a Comment